MBX Capital — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.
BiotechDigital HealthMental Health
Dr. John Krystal(Co-founder & CEO)inDina Burkitbayeva(Co-founder)in
Co-investorsBeni Venture CapitalEvolution VC PartnersIter InvestmentsLongeVCManta Ray VenturesPsyMed Ventures+1 more
OFFOR Health provides mobile healthcare services to underserved populations in the United States, operating SmileMD for in-office anesthesia and sedation during pediatric dental procedures and IH Care+ for integrated health access.
Digital HealthHealthtechMedical DevicesWorthington, US
Gary Schafer(Chief Executive Officer)inAlex Ramos(Chief Operations Officer)Brian Schloss(Chief Medical Officer)in
Co-investorsAtlantic Vantage PointAXA Venture PartnersHavencrest Capital ManagementLOUD CapitalSPRINGROCK VENTURES
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.